pacDNA
PrivateLast Round
Grant
Jan 17, 2025
Total Funding Raised
$2.99M
Company Overview
pacDNA operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in January 2025.
pacDNA is a biotechnology company that develops oligonucleotide therapeutics for the treatment of cancer and rare genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
pacDNA Comparables
Compare pacDNA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Entos Pharmaceuticals | 75% | |
| PepGen | 72% | |
| Avidity Biosciences | 68% |
For institutional investors. Book with your work email.
pacDNA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 17, 2025 | ||||
| Grant | Sep 1, 2023 | ||||
| Grant | Dec 1, 2022 | ||||
| Accelerator | Sep 1, 2022 | ||||
| Grant | Jul 1, 2022 |
For institutional investors. Book with your work email.
pacDNA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Congressionally Directed Medical Research Programs | Grant |
| Northeastern University Center for Research Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 17, 2025
$490K grant from Congressionally Directed Medical Research Programs
- Sep 1, 2023
$50K grant received from Northeastern University Center for Research Innovation.
For institutional investors. Book with your work email.
pacDNA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about pacDNA's valuation, stock price, and market status.
Is pacDNA a public or private company?
pacDNA is a private company.
What is the current stock price of pacDNA?
pacDNA is a private company, so its shares have no public market price. Caplight tracks pacDNA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is pacDNA worth (valuation)?
Valuation information for pacDNA is not publicly available.
Can I buy pacDNA stock?
pacDNA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was pacDNA's last funding round?
pacDNA's most recent funding round was Grant on January 17, 2025.
Who are the main investors in pacDNA?
Key investors in pacDNA include NIH RADx, Congressionally Directed Medical Research Programs, Northeastern University Center for Research Innovation.
Will pacDNA IPO soon?
No public IPO plans have been announced for pacDNA.
How can I track pacDNA secondary market activity?
Caplight tracks bids, offers, and trades in pacDNA's shares on secondary markets.